Comparison of hospital length of stay of acute ischemic stroke patients with non-valvular atrial fibrillation started on rivaroxaban or warfarin treatment during hospitalization

References

• Inoue H, Fujiki A, Origasa H, et al. Prevalence of atrial fibrillation in the general population of Japan: an analysis based on periodic health examination. Int J Cardiol. 2009;137(2):102–107.
   PubMed Web of Science ®Google Scholar
• Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22(8):983–988.
   PubMed Web of Science ®Google Scholar
• Appelros P, Nydevik I, Seiger Å, et al. Predictors of severe stroke: influence of preexisting dementia and cardiac disorders. Stroke. 2002;33(10):2357–2362.
   PubMed Web of Science ®Google Scholar
• Lin H-J, Wolf PA, Kelly-Hayes M, et al. Stroke severity in atrial fibrillation: the Framingham Study. Stroke. 1996;27(10):1760–1764.
   PubMed Web of Science ®Google Scholar
• Lai SM, Alter M, Friday G, et al. A multifactorial analysis of risk factors for recurrence of ischemic stroke. Stroke. 1994;25:958–962.
   PubMed Web of Science ®Google Scholar
• January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64(21):e1–e76.
   PubMed Web of Science ®Google Scholar
• Toyoda K, Arihiro S, Todo K, et al. Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study. Int J Stroke. 2015;10:836–842.
   PubMed Web of Science ®Google Scholar
• The Joint Committee on Guidelines for the Management of Stroke, The Japan Stroke Society. Japanese Guidelines for the Management of Stroke 2015. 2017 Supplement. [cited 2019 Apr 17]. Available from: http://www.jsts.gr.jp/img/guideline2015_tuiho2017.pdf.
   Google Scholar
• Farr AM, Jing Y, Johnston S, et al. Comparison of hospital length of stay between hospitalized non-valvular atrial fibrillation patients treated with either apixaban or warfarin. Hosp Pract. 2015;43(3):172–179.
   Google Scholar
• Laliberté F, Pilon D, Raut MK, et al. Hospital length of stay: is rivaroxaban associated with shorter inpatient stay compared to warfarin among patients with non-valvular atrial fibrillation? Curr Med Res Opin. 2014;30(4):645–653.
   PubMed Web of Science ®Google Scholar
• Fonseca E, Sander SD, Hess GP, et al. Hospital admissions, costs, and 30-day readmissions among newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran etexilate or warfarin. J Manag Care Spec Pharm. 2015;21(11):1039–1053.
   PubMed Web of Science ®Google Scholar
• Gilligan AM, Gandhi P, Song X, et al. All-cause, stroke-, and bleed-specific healthcare costs: comparison among patients with non-valvular atrial fibrillation (NVAF) newly treated with dabigatran or warfarin. Am J Cardiovasc Drugs. 2017;17(6):481–492.
   PubMed Web of Science ®Google Scholar
• Deitelzweig S, Luo X, Gupta K, et al. Effect of apixaban versus warfarin use on health care resource utilization and costs among elderly patients with nonvalvular atrial fibrillation. JMCP. 2017;23(11):1191–1201.
   PubMed Web of Science ®Google Scholar
• Clayville LR, Anderson KV, Miller SA, et al. New options in anticoagulation for the prevention of venous thromboembolism and stroke. Pharm Ther. 2011;36:86–99.
   Google Scholar
• Sakamoto H, Rahman M, Nomura S, et al. Japan Health System Review. New Delhi: World Health Organization, Regional Office for South-East Asia; 2018.
   Google Scholar
• Deguchi I, Takao M, Hayashi T, et al. Effect of oral anticoagulation therapy on duration of hospital stay and medical costs in patients with cardiogenic embolism stroke who were discharged to home. Jpn J Stroke. 2016;38(3):155–160.
   Google Scholar
• Yamashita T, Fukaya T, Kuroki D, et al. Comparison of the length of stay in patients and initiated with dabigatran or warfarin for a concomitant non-valvular atrial fibrillation in real-world Japanese therapeutic practice (SHORT J). Ther Res. 2017;38:377–391.
   Google Scholar
• Ishii M. DRG/PPS and DPC/PDPS as prospective payment systems. Jpn Med Assoc J. 2012;55:279–291.
   PubMedGoogle Scholar
• Koretsune Y, Yamashita T, Yasaka M, et al. Usefulness of a healthcare database for epidemiological research in atrial fibrillation. J Cardiol. 2017;70:169–179.
   PubMed Web of Science ®Google Scholar
• Koretsune Y, Yamashita T, Yasaka M, et al. Comparative effectiveness and safety of warfarin and dabigatran in patients with non-valvular atrial fibrillation in Japan: a claims database analysis. J Cardiol. 2019;73:204–209.
   PubMed Web of Science ®Google Scholar
• Sung S-F, Hsieh C-Y, Kao Yang Y-H, et al. Developing a stroke severity index based on administrative data was feasible using data mining techniques. J Clin Epidemiol. 2015;68:1292–1300.
   PubMed Web of Science ®Google Scholar
• Brott T, Adams HP, Jr Olinger CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20:864–870.
   PubMed Web of Science ®Google Scholar
• Sung S-F, Hsieh C-Y, Lin H-J, et al. Validity of a stroke severity index for administrative claims data research: a retrospective cohort study. BMC Health Serv Res. 2016;16:509.
   PubMed Web of Science ®Google Scholar
• Austin PC. Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Commun Stat Simul Comput. 2009;38(6):1228–1234.
   Web of Science ®Google Scholar
• Fujimoto Y, Kajikawa R, Izutsu N, et al. Choice behavior of attending physicians toward oral anticoagulants for secondary prevention of cardiogenic cerebral embolism. Jpn J Stroke. 2016;38(4):239–244.
   Google Scholar
• Chang K-C, Tseng M-C, Weng H-H, et al. Prediction of length of stay of first-ever ischemic stroke. Stroke. 2002;33:2670–2674.
   PubMed Web of Science ®Google Scholar
• Kang J-H, Bae H-J, Choi Y-A, et al. Length of hospital stay after stroke: a Korean nationwide study. Ann Rehabil Med. 2016;40:675–681.
   PubMedGoogle Scholar